Shares of DexCom, Inc. (NASDAQ:DXCM – Get Free Report) were down 4.9% on Wednesday after The Goldman Sachs Group lowered their price target on the stock from $104.00 to $89.00. Following the completion of the sale, the director owned 22,667 shares of the company’s stock, valued at approximately $1,832,853.62. Following the completion of the sale, the director directly owned 51,121 shares of the company’s stock, valued at $4,143,868.26. Finally, Nuveen LLC bought a new position in shares of DexCom in the first quarter valued at approximately $554,893,000. DexCom Stock Down 1.8%The company has a debt-to-equity ratio of 0.48, a current ratio of 1.52 and a quick ratio of 1.35.